These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30181771)

  • 1. A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome.
    Liu L; Du B; Zhang H; Guo X; Zhou Z; Xiu A; Liu C; Su S; Ai H
    Chin Med; 2018; 13():46. PubMed ID: 30181771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.
    Xu W; Tang M; Wang J; Wang L
    Evid Based Complement Alternat Med; 2020; 2020():4086864. PubMed ID: 32148541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms.
    Wang S; Tong Y; Ng TB; Lao L; Lam JK; Zhang KY; Zhang ZJ; Sze SC
    Chin Med; 2015; 10():19. PubMed ID: 26191080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
    Yu J; Fu Y; Zeng L; Zheng Y
    Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Pharmacology Uncovers Multiple Mechanisms of Erxian Decoction () for Treatment of Premature Ovarian Failure.
    Du B; Liu LH; Lv YJ; Ai H
    Chin J Integr Med; 2020 Feb; 26(2):106-113. PubMed ID: 31385218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
    Shi N; Zhou Y; Ma H
    Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the molecular targets and mechanism of
    Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
    Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
    Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
    J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
    Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
    Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erxian Decoction Attenuates TNF-α Induced Osteoblast Apoptosis by Modulating the Akt/Nrf2/HO-1 Signaling Pathway.
    Wang N; Xin H; Xu P; Yu Z; Shou D
    Front Pharmacol; 2019; 10():988. PubMed ID: 31551787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach.
    Chen Y; Chai X; Zhao Y; Yang X; Zhong C; Feng Y
    Evid Based Complement Alternat Med; 2021; 2021():6843828. PubMed ID: 34956381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
    Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
    World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
    Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
    Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
    Ma K; Gong LJ; Chen YX; Tian CD
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidogenic effect of Erxian decoction for relieving menopause via the p-Akt/PKB pathway in vitro and in vivo.
    Wang SW; Cheung HP; Tong Y; Lu J; Ng TB; Zhang YB; Zhang ZJ; Lee KF; Lam JK; Sze SC
    J Ethnopharmacol; 2017 Jan; 195():188-195. PubMed ID: 27871904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erxian decoction, a Chinese herbal formula, for menopausal syndrome: An updated systematic review.
    Wang Y; Lou XT; Shi YH; Tong Q; Zheng GQ
    J Ethnopharmacol; 2019 Apr; 234():8-20. PubMed ID: 30658181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
    Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
    Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.